Multiple sclerosis, a neuroinflammatory disease that affects nearly 3 million people worldwide, causes a loss of myelin, the ...

Scientists say IRX4204 given to mice with evident symptoms showed potential "as a remyelinating and neurorestorative ...

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

An investigational drug for multiple sclerosis from Io Therapeutics ... disease is caused by the erosion of a protective sheath, made of myelin, that normally surrounds nerve cells.

Multiple sclerosis (MS) leads to the breakdown of the protective fatty covering called myelin that wraps around nerves in your spinal cord and brain. Loss of myelin leads to impaired nerve ...

Conducted in the wake of the vicious October 7, 2023, terrorist attack by Hamas, the study is among the few in the world to ...

Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases, announced today it has received clinical trial ...

Sphingosine is a membrane component in all cells and constitutes 25% of the lipid in the myelin sheath. Sphingosine is phosphorylated by ubiquitously expressed sphingosine kinases. S1P regulates ...

Using microglia, astrocytes and oligodendrocyte progenitor cells, additional data was obtained suggesting that IRX4204 acts on multiple glial subtypes to orchestrate myelin repair. George S.